- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06228742
Molecular Mechanisms Underlying Anabolic Resistance to Protein Intake During Muscle Disuse
April 5, 2024 updated by: Emily E. Howard, United States Army Research Institute of Environmental Medicine
Molecular Regulation of Skeletal Muscle Anabolic Resistance to Dietary Protein in Response to Injury-mediated Muscle Disuse
This study will characterize intramuscular molecular mechanisms underlying anabolic resistance to protein ingestion during muscle disuse.
Adults (n=12) will be studied using a unilateral leg immobilization model in which one leg will be randomly assigned to immobilization and the contralateral, active leg used as a within-subjects control.
Immobilization will be implemented for five days using a rigid knee brace, during which time participants will ambulate using crutches.
Integrated ribonucleic acid (RNA) synthesis will be determined during immobilization in the immobilized and non-immobilized legs using ingested deuterium oxide, salivary and blood sampling, and muscle biopsies.
Immediately after immobilization, muscle biopsies will be collected before and 90 mins after consuming 25 g of whey protein from the immobilized and non-immobilized legs to characterize the intramuscular molecular response to protein feeding.
Serial blood samples will be collected during that time to characterize the circulating metabolic response to protein ingestion.
Knowledge generated from this effort will inform the development of targeted interventions for mitigating anabolic resistance to protein ingestion that develops during periods of muscle disuse.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Warfighters that sustain musculoskeletal injuries often experience decreased muscle loading and activation post-injury (i.e., muscle disuse) that results in a rapid loss of muscle mass and function.
Loss of muscle under these conditions is attributed to a persistent negative net muscle protein balance (muscle protein synthesis [MPS] < muscle protein breakdown [MPB]) that results, in part, from a blunting of MPS in the postprandial state.
Nutritional interventions that optimize postprandial MPS have been suggested as countermeasures for this "anabolic resistance" that develops during disuse to preserve muscle mass and accelerate return to duty.
However, a poor understanding of mechanisms underlying anabolic resistance during disuse has made it difficult to determine an optimal nutritional intervention.
The current study will address this knowledge gap directly by characterizing intramuscular molecular mechanisms underlying anabolic resistance to protein ingestion during muscle disuse.
Healthy, recreationally active men and women (n=12) will be studied using a within-subjects, unilateral design.
After completing baseline measures of height, weight, and body composition, participants will begin a 3-day run-in phase where they will receive diet instructions (no food provided).
Muscle disuse will then be implemented for 5 days using a unilateral leg immobilization model with one leg randomly assigned to immobilization and the contralateral, active leg used as a within-subjects control.
Immobilization will be implemented using a rigid knee brace, and participants will ambulate using crutches.
Diets will be standardized during the immobilization phase (1.0 g protein/kg/d, 30% of energy intake from fat, and the remaining calories from carbohydrate).
Integrated ribonucleic acid (RNA) synthesis will be determined during immobilization in the immobilized and non-immobilized legs using ingested deuterium oxide, salivary and blood sampling, and muscle biopsies.
Immediately after immobilization, muscle biopsies will be collected before and 90 mins after consuming 25 g of whey protein from the immobilized and non-immobilized legs to characterize the intramuscular molecular response to protein feeding.
Serial blood samples will be collected during that time to characterize the circulating metabolic response to protein ingestion.
Knowledge generated from this effort will inform the development of targeted interventions for mitigating anabolic resistance to protein ingestion that develops during periods of muscle disuse.
Study Type
Interventional
Enrollment (Estimated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emily E Howard, PhD
- Phone Number: 508-206-2309
- Email: emily.e.howard14.civ@health.mil
Study Locations
-
-
Massachusetts
-
Natick, Massachusetts, United States, 01760
- Recruiting
- US Army Research Institute of Environmental Medicine
-
Contact:
- Emily E Howard, PhD
- Phone Number: 508-206-2309
- Email: emily.e.howard14.civ@health.mil
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Men and women aged 18-39 years.
- Body mass index (BMI) between 18.5-30 kg/m2
- Healthy without evidence of chronic illness (e.g., diabetes, cardiovascular disease, Crohn's disease) or musculoskeletal injury as determined by the USARIEM Office of Medical Oversight (OMSO) or home duty station medical support.
- Routinely participate in aerobic and/or resistance exercise at least 2 days per week.
- Willing to refrain from alcohol, smoking, smokeless nicotine products (includes e-cigarettes, vaping, chewing tobacco), caffeine, and dietary supplements (i.e., vitamin D, probiotics) during the run-in diet, immobilization phase, and final testing day of the study.
- Supervisor approval for federal civilian employees and non-human research volunteer (HRV) active-duty military personnel stationed at Natick Soldier System Center (NSSC).
- Biological females must have normal menstrual cycles between 26-32 days in duration; 5 menstrual cycles within the past 6 months; or on continuous hormonal contraception (i.e., intrauteraine device (IUD) or oral contraceptives without placebo).
Exclusion Criteria:
- Musculoskeletal injuries that may interfere with the safe use of crutches.
- Personal or family history of thrombosis, or prior diagnosis of deep vein thrombosis (DVT) or pulmonary embolism (PE).
- Metabolic or cardiovascular abnormalities, gastrointestinal disorders, neuromuscular disorders, lower-limb amputation, or muscle/bone wasting disorders (e.g., diabetes, cardiovascular disease, Crohn's disease, etc.).
- Significantly abnormal blood clotting as determined by OMSO or home duty station medical support.
- Allergy to lidocaine (or similar local anesthetic)
- Present condition of alcoholism, anabolic steroid use, or other substance abuse issues as determined by OMSO or home duty station medical support.
- Blood donation within 8-wk of beginning the study.
- Pregnant, trying to become pregnant, and/or breastfeeding (results of urine pregnancy test and self-report for breastfeeding will be obtained before body composition testing).
- Unwilling or unable to consume study diets or foods provided due to personal preference and/or food allergies.
- Unwilling or unable to adhere to study physical restrictions (i.e., no structured physical activity or recreational activity beyond activities of daily living) 24 hours before and during immobilization, and the final testing day.
- Unwilling or unable to keep the knee brace on and walk with crutches during the immobilization phase.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immobilized Leg
One leg of a young, healthy adult will be randomly assigned to undergo 5 days of immobilization using a rigid knee brace.
|
Participants will have one leg immobilized using a rigid knee brace.
Participants will be expected to keep the knee brace on for 5 days and remain non-weight bearing on the immobilized leg.
Participants will use crutches to remain non-weight bearing on the immobilized leg.
Other Names:
|
Experimental: Non-immobilized leg
One leg of a young, healthy adult will remain active and not immobilized for 5 days.
|
One leg will remain non-immobilized and active during the study.
Participants will use this leg to walk with crutches.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Integrated ribonucleic acid (RNA) synthesis
Time Frame: 5 days
|
deuterium oxide coupled with muscle biopsies
|
5 days
|
Intramuscular protein signaling response to protein ingestion
Time Frame: 90 minutes
|
muscle biopsies to assess protein signaling response to consuming 25 g of whey protein
|
90 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Emily E Howard, PhD, US Army Research Institute of Environmental Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 20, 2024
Primary Completion (Estimated)
May 1, 2025
Study Completion (Estimated)
May 1, 2025
Study Registration Dates
First Submitted
January 18, 2024
First Submitted That Met QC Criteria
January 18, 2024
First Posted (Actual)
January 29, 2024
Study Record Updates
Last Update Posted (Actual)
April 8, 2024
Last Update Submitted That Met QC Criteria
April 5, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscular Disorders, Atrophic
-
Camilo Jose Cela UniversityCompletedMuscular Disorders, AtrophicSpain
-
University of WarwickNorthern Care Alliance NHS Foundation Trust; University Hospitals Coventry... and other collaboratorsUnknown
-
Maastricht University Medical CenterCompleted
-
Texas Christian UniversityRecruiting
-
Logan College of ChiropracticUnknown
-
St Mary's University CollegeNot yet recruitingAtrophy, Muscular | Atrophy, Disuse
-
University of Sao PauloCompleted
-
McMaster UniversityRecruitingHealthy | Muscle Disuse AtrophyCanada
-
Maastricht University Medical CenterCompletedImmobilization | Neuromuscular Electrical Stimulation | Disuse AtrophyNetherlands
-
Centre d'Investigation Clinique et Technologique...Unknown
Clinical Trials on Unilateral leg immobilization
-
McMaster UniversityMyos CorporationCompletedNutrition, Healthy | Muscle Disuse AtrophyCanada
-
McGill UniversityRecruitingMuscle Atrophy | Muscle Disuse AtrophyCanada
-
Brigham Young UniversityRecruitingMuscular Atrophy | Massage TherapyUnited States
-
McMaster UniversityActive, not recruitingMuscle Protein Synthesis | Menstrual Cycle | Resistance ExerciseCanada
-
Prisma Health-UpstateCompletedTibial FracturesUnited States
-
Texas Christian UniversityRecruiting
-
McMaster UniversityNot yet recruiting
-
McMaster UniversityCompletedMuscle Atrophy | Disuse Atrophy (Muscle) of Lower LegCanada
-
McMaster UniversityAxcella Health, IncCompleted
-
University of CopenhagenRadboud University Medical Center; University of Leeds; Johannes Gutenberg University... and other collaboratorsCompletedPhysical Activity | Immobilization, TonicDenmark